ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $9,294,000 | +133.3% | 100,000 | +49.5% | 0.10% | +131.1% |
| Q3 2021 | $3,983,000 | -51.3% | 66,900 | -44.2% | 0.04% | -57.5% |
| Q2 2021 | $8,186,000 | +293.2% | 120,000 | +300.0% | 0.11% | +140.9% |
| Q1 2021 | $2,082,000 | -55.0% | 30,000 | -50.2% | 0.04% | -58.5% |
| Q4 2020 | $4,624,000 | +54.5% | 60,200 | +50.5% | 0.11% | +51.4% |
| Q3 2020 | $2,992,000 | -48.8% | 40,000 | -56.9% | 0.07% | -64.1% |
| Q2 2020 | $5,841,000 | +895.1% | 92,781 | +827.8% | 0.20% | +550.0% |
| Q2 2019 | $587,000 | -47.6% | 10,000 | -60.0% | 0.03% | -51.6% |
| Q1 2019 | $1,121,000 | – | 25,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |